Balance Sheet
Cash Flow Statement
AmortizationAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Change in Account Payables (2020 - 2025)

Historic Change in Account Payables for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to $24.3 million.

  • Legend Biotech's Change in Account Payables rose 28931.97% to $24.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $66.3 million, marking a year-over-year increase of 35073.89%. This contributed to the annual value of $14.1 million for FY2024, which is 12800.74% up from last year.
  • Per Legend Biotech's latest filing, its Change in Account Payables stood at $24.3 million for Q3 2025, which was up 28931.97% from $16.5 million recorded in Q2 2025.
  • Legend Biotech's Change in Account Payables' 5-year high stood at $41.9 million during Q4 2022, with a 5-year trough of -$34.5 million in Q4 2023.
  • Its 5-year average for Change in Account Payables is $5.7 million, with a median of $2.7 million in 2022.
  • As far as peak fluctuations go, Legend Biotech's Change in Account Payables soared by 15658333.56% in 2021, and later crashed by 43002.0% in 2023.
  • Legend Biotech's Change in Account Payables (Quarter) stood at -$4.6 million in 2021, then surged by 1021.8% to $41.9 million in 2022, then crashed by 182.21% to -$34.5 million in 2023, then surged by 117.51% to $6.0 million in 2024, then surged by 302.04% to $24.3 million in 2025.
  • Its Change in Account Payables stands at $24.3 million for Q3 2025, versus $16.5 million for Q2 2025 and $19.5 million for Q1 2025.